Sponsored Ads
Home » Search » Abraxis BioScience Inc.
Category
Title
Summary
Date
Summaries
Patent Law >
New Settlements and Verdicts
Patent Law >
New Settlements and Verdicts
The patent at issue (‘363 patent) is entitled “Surface Modified Anticancer Particles.” Another one (‘025 patent) is entitled “reduction of Intravenously Administered nanoparticulate-Formulation-Induced Adverse Physiological Reactions”. Plaintiff Elan Pharmaceutical International Limited, Ireland’s biggest drug maker, asserted in its complaint that defendant Abraxis Bioscience, Inc. “has been, and currently is, directly…
Date of ruling:
06/13/2008
06/13/2008
